CD47 and neoplasm: As blocking CD47 (an integrin-associated transmembrane protein that serves as a ‘don’t eat me’ signal for macrophages and dendritic cells) can stimulate the innate immune system, Chen et al. assessed the potential for combining BNCT with CD47 inhibition as a means of improving tumor response in a mouse glioma model.